{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "marketState": "PREPRE", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "esgPopulated": false, "regularMarketChangePercent": -2.7874565, "regularMarketPrice": 1116.0, "exchange": "JPX", "shortName": "DELTA FLY PHARMA INC", "longName": "Delta-Fly Pharma, Inc.", "messageBoardId": "finmb_171577594", "exchangeTimezoneName": "Asia/Tokyo", "market": "jp_market", "regularMarketTime": 1683872101, "regularMarketDayHigh": 1152.0, "regularMarketDayRange": "1116.0 - 1152.0", "regularMarketDayLow": 1116.0, "regularMarketVolume": 205400, "regularMarketPreviousClose": 1148.0, "bid": 1116.0, "ask": 1122.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 1152.0, "averageDailyVolume3Month": 1273950, "averageDailyVolume10Day": 273740, "fiftyTwoWeekLowChange": 367.0, "fiftyTwoWeekLowChangePercent": 0.48998666, "fiftyTwoWeekRange": "749.0 - 1560.0", "fiftyTwoWeekHighChange": -444.0, "fiftyTwoWeekHighChangePercent": -0.2846154, "fiftyTwoWeekLow": 749.0, "fiftyTwoWeekHigh": 1560.0, "earningsTimestamp": 1684148340, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684148340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -217.54, "epsForward": -18.5, "sharesOutstanding": 5419440, "bookValue": 135.373, "fiftyDayAverage": 1266.38, "fiftyDayAverageChange": -150.38, "fiftyDayAverageChangePercent": -0.11874793, "twoHundredDayAverage": 1084.05, "twoHundredDayAverageChange": 31.949951, "twoHundredDayAverageChangePercent": 0.029472765, "marketCap": 6048095232, "forwardPE": -60.324326, "priceToBook": 8.243889, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1539302400000, "priceHint": 2, "regularMarketChange": -32.0, "symbol": "4598.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "37-5 Nishikino", "address2": "Miyajima Kawauchi-cho", "city": "Tokushima", "zip": "771-0116", "country": "Japan", "website": "https://www.delta-flypharma.co.jp", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 that is in phase III clinical trial in the United States and phase I trial in Japan for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323, which is in phase II clinical trial to treat lung cancer; DFP-17729 that is in phase I/II clinical trials for the treatment of solid cancer; DFP-11207, which has completed phase I clinical trial to treat pancreatic cancer; DFP-14927 that is in phase I for the treatment of hematologic cancer; and DFP-10825, which is in preclinical trial to treat gastric/ovarian cancer. The company was incorporated in 2010 and is headquartered in Tokushima, Japan.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kiyoshi  Eshima", "age": 73, "title": "Pres, Founder & Director", "yearBorn": 1949, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yasuo  Matsueda", "age": 62, "title": "CFO, Head of Bus. Devel. & Director", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}